Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Angelika Eggert

Full Professor of Pediatrics & Director

Charité - Universitätsmedizin Berlin

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

50%

Cell Biology

60%

Cancer Biology

50%

Oncology

50%

Neuroblastoma

40%

Targeted Therapy

30%

Cancer Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

Article Link

Year:

2024

Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models

Article Link

Year:

2024

Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer.

Article Link

Year:

2024

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Article Link

Year:

2023

Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease.

Article Link

Year:

2023

X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

Article Link

Year:

2023

Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform

Article Link

Year:

2023

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy

Article Link

Year:

2023

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.

Article Link

Year:

2023

Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells.

Article Link

Year:

2023

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse

Article Link

Year:

2023

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients.

Article Link

Year:

2023

Mutational topography reflects clinical neuroblastoma heterogeneity.

Article Link

Year:

2023

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics

Article Link

Year:

2022

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model.

Article Link

Year:

2022

Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry

Article Link

Year:

2022

Collaborators15

Jörg Fallmann

Leipzig University

GERMANY

Tobias Herold

University Hospital, LMU Munich

GERMANY

Michael Hummel

Charité - Universitätsmedizin Berlin

GERMANY

Jennifer Kirwan

Head of Platform

Max Delbrück Center for Molecular Medicine

GERMANY

Hedwig E. Deubzer

GERMANY

Holger Lode

Professor and Chair of Pediatrics

University Medicine Greifswald

GERMANY

Anja Kühl

Head & PI /Ph.D.

Charité - Universitätsmedizin Berlin

GERMANY

Raphaela Fritsche

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

Victor Bardinet

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

Johannes Hubertus Schulte

Head of Pediatric Stem Cell Transplantation; Professor of Pediatric Oncology Research

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

Georg Seifert

Charité - Universitätsmedizin Berlin

GERMANY

Michael Launspach

Charité

GERMANY

Boris Hadaschik

Universität Duisburg-Essen

GERMANY

Peter Lang

GERMANY

Aleksandra Wieczorek

Jagiellonian University Medical College

POLAND

How do I reach out?

Meet Kite AI